PURPOSE: CMV infection remains a priority for vaccine development. Vaccination of infants could modify congenital infection and provide lifetime immunity. Properties of CMV-specific T cells associated with control of viral replication in early life have not been fully defined. METHODS: CMV-specific CD4 and CD8 T cell responses were investigated in infants with congenital CMV infection and compared to adults with primary or chronic infection. PBMC were stimulated with UL83 (pp65) or UL122 (IE-2) peptide pools then stained with antibodies to markers of T cell subset (CD4 or CD8), phenotype (CD45RA, CCR7), or function (MIP1β, CD107, IFNγ, IL2) for flow cytometry analysis. RESULTS: Detection of CMV pp65-specific CD4 T cells was less common in infants than adults. Responder cells were primarily effector memory (EM, CD45RA-CCR7-) in adults, but mixed memory subsets in infants. Detection of CMV pp65-specific CD8 T cells did not differ between the groups, but infants had lower frequencies of total responding cells and of MIP1β- or CD107-expressing cells. Responder cells were EM or effector memory RA (CD45RA + CCR7-) in all groups. Polyfunctional T cells were less commonly detected in infants than adults. Responses to IE-2 were detected in adults but not infants. All infants had detectable circulating CMV DNA at initial study (versus 60 % of adults with primary infection) despite longer duration of CMV infection. CONCLUSIONS: Reduced frequencies and altered functional profile of CMV-specific CD4 and CD8 T cell responses were detected in infants compared to adults, and were associated with persistent CMV DNA in peripheral blood.
PURPOSE:CMV infection remains a priority for vaccine development. Vaccination of infants could modify congenital infection and provide lifetime immunity. Properties of CMV-specific T cells associated with control of viral replication in early life have not been fully defined. METHODS: CMV-specific CD4 and CD8 T cell responses were investigated in infants with congenital CMV infection and compared to adults with primary or chronic infection. PBMC were stimulated with UL83 (pp65) or UL122 (IE-2) peptide pools then stained with antibodies to markers of T cell subset (CD4 or CD8), phenotype (CD45RA, CCR7), or function (MIP1β, CD107, IFNγ, IL2) for flow cytometry analysis. RESULTS: Detection of CMV pp65-specific CD4 T cells was less common in infants than adults. Responder cells were primarily effector memory (EM, CD45RA-CCR7-) in adults, but mixed memory subsets in infants. Detection of CMV pp65-specific CD8 T cells did not differ between the groups, but infants had lower frequencies of total responding cells and of MIP1β- or CD107-expressing cells. Responder cells were EM or effector memory RA (CD45RA + CCR7-) in all groups. Polyfunctional T cells were less commonly detected in infants than adults. Responses to IE-2 were detected in adults but not infants. All infants had detectable circulating CMV DNA at initial study (versus 60 % of adults with primary infection) despite longer duration of CMV infection. CONCLUSIONS: Reduced frequencies and altered functional profile of CMV-specific CD4 and CD8 T cell responses were detected in infants compared to adults, and were associated with persistent CMV DNA in peripheral blood.
Authors: Johan K Sandberg; Noam M Fast; Kimberly A Jordan; Scott N Furlan; Jason D Barbour; Glenn Fennelly; Joanna Dobroszycki; Hans M L Spiegel; Andrew Wiznia; Michael G Rosenberg; Douglas F Nixon Journal: J Immunol Date: 2003-04-15 Impact factor: 5.422
Authors: A K Lidehäll; M-L Engman; F Sund; G Malm; I Lewensohn-Fuchs; U Ewald; T H Tötterman; E Karltorp; O Korsgren; B-M Eriksson Journal: Scand J Immunol Date: 2013-02 Impact factor: 3.487
Authors: Nicole Ritz; Madeleine Strach; Carmen Yau; Binita Dutta; Marc Tebruegge; Tom G Connell; Willem A Hanekom; Warwick J Britton; Roy Robins-Browne; Nigel Curtis Journal: PLoS One Date: 2012-07-19 Impact factor: 3.240
Authors: Arnaud Marchant; Victor Appay; Marianne Van Der Sande; Nicolas Dulphy; Corinne Liesnard; Michael Kidd; Steve Kaye; Olubukola Ojuola; Geraldine M A Gillespie; Ana L Vargas Cuero; Vincenzo Cerundolo; Margaret Callan; Keith P W J McAdam; Sarah L Rowland-Jones; Catherine Donner; Andrew J McMichael; Hilton Whittle Journal: J Clin Invest Date: 2003-06 Impact factor: 14.808
Authors: Nicholas Renzette; Cornelia Pokalyuk; Laura Gibson; Bornali Bhattacharjee; Mark R Schleiss; Klaus Hamprecht; Aparecida Y Yamamoto; Marisa M Mussi-Pinhata; William J Britt; Jeffrey D Jensen; Timothy F Kowalik Journal: Proc Natl Acad Sci U S A Date: 2015-07-06 Impact factor: 11.205
Authors: Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar Journal: J Infect Dis Date: 2020-03-05 Impact factor: 5.226
Authors: Eddie A James; Theresa J Gates; Rebecca E LaFond; Shinobu Yamamoto; Chester Ni; Duy Mai; Vivian H Gersuk; Kimberly O'Brien; Quynh-Anh Nguyen; Brad Zeitner; Marion C Lanteri; Philip J Norris; Damien Chaussabel; Uma Malhotra; William W Kwok Journal: PLoS Pathog Date: 2016-01-21 Impact factor: 6.823
Authors: Ashley N Nelson; Nicole Putnam; Debra Hauer; Victoria K Baxter; Robert J Adams; Diane E Griffin Journal: Sci Rep Date: 2017-09-13 Impact factor: 4.379